Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03854799
Title Immunotherapy In Locally Advanced Rectal Cancer (AVANA)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gruppo Oncologico del Nord-Ovest
Indications

rectum adenocarcinoma

Therapies

Avelumab + Capecitabine

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.